Literature DB >> 1525650

Immediate or delayed mild hypothermia prevents focal cerebral infarction.

D Xue1, Z G Huang, K E Smith, A M Buchan.   

Abstract

The protective effect of mild hypothermia was studied in rodent models of both permanent and transient focal cerebral ischemia. In Expt. 1, Wistar rats were exposed to 6 h permanent ischemia by bilateral occlusion of both common carotid arteries and right middle cerebral artery. In Expt. 2, animals were exposed to 3 h transient ischemia followed by 21 h reperfusion, and in Expt. 3, 3 h transient ischemia was followed by 69 h of reperfusion. Expt. 4 used 3 h transient ischemia followed by 3 h reperfusion. In Expt. 1, animals maintained at 37 degrees C rectal (normothermia) suffered a mean infarct volume (+/- S.D.) of 142 +/- 44 mm3 (n = 6), which was reduced for those exposed to permanent hypothermic (32 degrees C) ischemia to 56 +/- 64 mm3 (n = 10) (P less than 0.05). In Expt. 2, normothermic ischemia and reperfusion resulted in an infarction of 211 +/- 35 mm3 (n = 6). Intra-ischemic hypothermia (32 degrees C) followed by 21 h of normothermic reperfusion resulted in 17 +/- 12 mm3 of infarction (n = 9) (P less than 0.001). Hypothermia for either the first or second 1.5 h of the 3 h ischemic insult reduced the infarct volume to 116 +/- 76 mm3 (n = 6) (P less than 0.05) or 108 +/- 73 mm3 (n = 7) (P less than 0.01), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1525650     DOI: 10.1016/0006-8993(92)91428-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Safety evaluation of nasopharyngeal cooling (RhinoChill®) in stroke patients: an observational study.

Authors:  Sven Poli; Jan Purrucker; Miriam Priglinger; Marek Sykora; Jennifer Diedler; André Rupp; Cem Bulut; Werner Hacke; Christian Hametner
Journal:  Neurocrit Care       Date:  2014-02       Impact factor: 3.210

2.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 3.  Neuroprotection for ischemic stroke using hypothermia.

Authors:  Angelos-Aristeidis Konstas; Jae H Choi; John Pile-Spellman
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia.

Authors:  Carla M Webster; Stephen Kelly; Maya A Koike; Valerie Y Chock; Rona G Giffard; Midori A Yenari
Journal:  Neurobiol Dis       Date:  2008-11-19       Impact factor: 5.996

5.  Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism.

Authors:  S P Butcher; D C Henshall; Y Teramura; K Iwasaki; J Sharkey
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 6.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment.

Authors:  F Colbourne; G Sutherland; D Corbett
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

Review 7.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

8.  Increased Intracerebral Pressure Following Stroke.

Authors:  Thorsten Steiner; Ralf Weber; Derk Krieger
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.598

9.  Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection.

Authors:  Jed A Hartings; Michael L Rolli; X-C May Lu; Frank C Tortella
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

10.  A Head and Neck Support Device for Inducing Local Hypothermia.

Authors:  Adam Gladen; Paul A Iaizzo; John C Bischof; Arthur G Erdman; Afshin A Divani
Journal:  J Med Device       Date:  2013-12-06       Impact factor: 0.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.